4//SEC Filing
Seth Kiernan 4
Accession 0001127602-23-004944
CIK 0001062822other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:04 PM ET
Size
7.7 KB
Accession
0001127602-23-004944
Insider Transaction Report
Form 4
Seth Kiernan
VP, Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2023-02-09+93,370→ 93,370 total→ Common Stock (93,370 underlying) - Award
Stock Option (Right to Buy)
2023-02-09+280,100→ 280,100 totalExercise: $2.43Exp: 2033-02-09→ Common Stock (280,100 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
- [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001890439
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:04 PM ET
- Size
- 7.7 KB